InsidersTradesSigma
Track the 长春高新 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 长春高新 has recorded 19 public disclosures. Market capitalisation: €33.1bn. The latest transaction was filed on 16 August 2024 (Purchase). Among the most active insiders: 王志刚. All data is free.
19
Insider Decl.
n/a
Thresholds
€4m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 长春高新 Strong Buy (bullish), based on 1 analysts. Average price target: CN¥111.34.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,576 of 28,833 companies
34.7
score / 100
Value21
Quality49
FCF yld-4.2%
Earn yld0.5%
EV/EBITDA43.6x
ROE-0.9%
Gross mgn82%
Net mgn1.3%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 August 2024
Declarations19 total
19 of 19 declarations
About 长春高新
长春高新 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.